Current Research Projects Gary S. Rubin, PhD Helen Keller Professor of Ophthalmology UCL Institute of Ophthalmology Low Vision Patient Day 7 June 2014.

Slides:



Advertisements
Similar presentations
Eye Care Center at the Southern California College of Optometry MaryAnn Walls Low Vision Center Dr. Becky Kammer, Chief
Advertisements

Is Vision Loss Part of Getting Older?  Vision can change as we age.  Vision loss and blindness are not a normal part of aging.
Human Visual System and Retinal Blindness Retina is a light sensitive neural network Diseases such as Retinitis Pigmentosa (RP) and Age- related Macular.
Joint Finance Committee Hearing Fiscal Year 2016 Daniel M. Madrid, Division Director Tuesday, February 24, 2015 "Working in partnership with Delawareans.
The Bionic Eye JON GOLDBERG, BME 181 SECTION 3. The Problem The Photoreceptor ◦Photoreceptors signal the presence of light in the visual field. ◦Rods:
G UIDELINES FOR PRESCRIBING OPTICAL DEVICES AND TRAINING 23 February 2012.
UCL Institute of Ophthalmology Department of Genetics
Innovative Color Vision Testing (simultaneous congenital & acquired)
BIOPTIC DRIVING: APPLICATION & OUTCOMES TO LOW VISION DRIVING
Earth in Yellow Flower Presenter Name By PresenterMedia.comPresenterMedia.com By Sumitra Marda Optometrist, Ocularist, Low vision specialist, Sportvision.
A Controlled Study Of The Use Of BiOptic Telescopes By Patients With Macular Degeneration For Driving - With Follow-Up Janet Szlyk, PhD VA Chicago Health.
Vision for the Blind. Stat 19 SEM Talk 1. Vision for the Blind. Stat 19 SEM Talk 1. Alan Yuille. UCLA.
What are the characteristics of children with visual impairment in the era without Dr. James E. Jan? A review of the first 10 years since his retirement.
Deborah Gilden, Ph.D. Rehabilitation Engineering Research Center The Smith-Kettlewell Eye Research Institute.
March 9, 2006Driving with the Bioptic Telescope1 Presented By Dr. Dennis Kelleher California Department of Education.
Current and Upcoming Clinical Trials Now, let’s consider 2 treatments where few or no photoreceptor cells remain alive. Possible treatments here would.
Low Vision Aids.
Mobility Aid For The Blind By Amir Gonnen. The oldest aids Walking Cane Guide dog Problems: – Skills and Training phase – Range – Very little information.
LET’S TALK LOW VISION Suleiman Alibhai, O.D. Retina Group of Washington Krista M. Davis, O.D., F.A.A.O. Columbia Lighthouse for the Blind.
When a person has lost their sight to a damaged retina there is now technology that allows them to see again. By means of a chip which sends electrical.
1 Low Vision Rehabilitation Suleiman Alibhai, O.D. Doctor of Optometry Lions Clubs International IAG Mission Myanmar, 2013.
Driving with Low Vision Bill Takeshita, O.D.,F.A.A.O., F.C.O.V.D.
Tersia //Gowases: Can low vision users benefit from eye tracking? Computer interactions of low vision users.
Development of a home-based Eccentric Viewing training program for clients with age-related macular degeneration through a researcher-clinician partnership.
BASIC LOW VISION SERVICE NEW OPPORTUNITY OF SERVICE UNDER AVOIDABLE BLINDNESS INITIATIVE Presentation on Adaptable technology for “Low vision devices”
C ONFERENCE TOPICS INCLUDE ( BUT ARE NOT LIMITED TO ) Performance-based tests Reading Object recognition Postural stability, balance and falls Patient.
Evaluation of Feedback Mechanisms for Wearable Visual Aids Aminat Adebiyi, Nii Mante, Carey Zhang, Furkhan E. Sahin, Gerard G. Medioni Ph.D., Armand R.
IMPLANTABLE MINIATURE TELESCOPES An introduction by James Bole BSc (Hons). GCGI. MIfL Director – Vision Rehabilitation Ltd Vice Chair – RWPN Trustee.
Panel Questions 1.Please discuss the following regarding endothelial cell density: a.The primary safety endpoint for this study was mean ECD ≤ 17%. The.
WHAT IS RESEARCH? Catey Bunce Principal Statistician NIHR Biomedical Research Centre (BRC) at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute.
© 2013, 2009, 2006, 2003, 2000 Pearson Education, Inc. All rights reserved. William L. Heward Exceptional Children An Introduction to Special Education.
Chapter 10 Blindness and Low Vision
ARTIFICIAL EYE By U.Sandhya Rani 08A91A04A7.
إعداد / الطالب :: ضياء أبو رجيلة الطالب :: فؤاد النجار الطالب :: محمد شاهين إشراف م./ ياسمين البوبو 2010/2011 Second Argus.
The Role of Glare in Driving Gary S. Rubin Institute of Ophthalmology London, UK.
CHAPTER 3 Low Vision for O&M. What is Low Vision?  Definition has changed over the years  According to Foundation of Orientation and Mobility:  “…persons.
Visual Impairment. Factors Affecting Visual Function and Their Treatment Visual Acuity - ability to see "detail" –Measured using testing distance/letter.
The Argus II By: Ahmaad Randall. What is it? The world’s first approved device intended to restore some functional vision for people suffering from blindness.
Bionic Eyes Robert Blease. Target Current designs are made for patients with degenerative eye disorders. The most common disorder currently treatable.
Chapter 10 Blindness and Low Vision
Contrast and Low Vision Moorfields Eye Hospital, UCL & Kingston University London Rubin, Dalke, Corso and Riaz Research funded by Special Trustees of Moorfields.
Retinal and Cortical Implants. Stat 19 SEM Talk 4. The brain is a network of nerve cell, neurons. The neurons communicate by electrical and.
By Justin Martin.  Affects thousands of people each year  Retinitis Pigmentosa is the leading cause of inherited blindness. ◦ 1.5 million people are.
Punita Christopher, Fred K Chen, Varalakshmi Wuyyuru, Jose Sahel,
Visual Impairments Team: Christina Frydrych, Leslie Pachol Fall 2007.
«Ensuring earlier visual rehabilitation for patients with visual loss» Mona Nordvik Nurse and Quality coordinator Department of Ophthalmology Haukeland.
Blindness or low vision effects more than 3 million Americans 40 years and older, and this number is projected to reach 5.5 million by In addition.
By: Kyle Sexton BME 281, Section 2 October 2, 2012.
Artificial Retina Imaging for the Sight Impaired
CONTENTS INTRODUCTION WHO IS ELIGIBLE ? DEVICE WORKING
Artificial Retina Imaging for the Sight Impaired MONDAY, APRIL 18 MIKE VUE ARTIFICIAL RETINA ALLOWS SOMEONE WHO HAS LOST THEIR VISION TO SEE AGAIN. THE.
Southwest Center for Microsystems Education
ARTIFICIAL EYE
MS, DNB, FICO, CORNEA & REFRACTIVE SURGERY FELLOWSHIP
Dr Shegufta Farooq Research Orthoptist Department of Orthoptics,
The DEPression in Visual Impairment Trial:
COACHES & DIRECTORS TRAINING
Chapter 10 Blindness and Low Vision
Access to low vision services in a resource limited setting: Profile and Barriers Asik Pradhan1, Monica Chaudhry2 , Sanjeeb Bhandari1 1Tilganga Institute.
Chapter 10 Blindness and Low Vision
Driving with the Bioptic Telescope
Dr. Becky Kammer, Chief Eye Care Center at the Southern California College of Optometry MaryAnn Walls Low Vision Center Dr.
An Update on the Bionic Eye Project
Driving with the Bioptic Telescope
JAMA Ophthalmology Journal Club Slides: Outcomes of the Veterans Affairs Low Vision Intervention Trial II Stelmack JA, Tang XC, Wei Y, et al; LOVIT II.
Low vision rehabilitation: skills for occupational therapists
Driving Habits of Visually Impaired Drivers Who Use Bioptic Telescopes
Cases of ARMD in Low vision Jasmin modi 9/10/20191.
Presentation transcript:

Current Research Projects Gary S. Rubin, PhD Helen Keller Professor of Ophthalmology UCL Institute of Ophthalmology Low Vision Patient Day 7 June 2014

Topics Basic Research  Service Delivery New Devices  Training Two projects undertaken with colleagues from other parts of the University (Dept of Transportation Engineering)  and colleagues from other universities (School of Architecture, Kingston University

Is there Brain Remapping in Macular Disease? (Baseler, 2007) Specific areas of the brain process information from specific areas of the visual field AMD  central scotoma  silent areas of the brain Do these silent areas regain function? For vision – No For other senses – maybe Yes Response of Area V1 Silent brain areas before and after

Clinical Predictors of Reading Speed in AMD ( Rubin & Feely, 2009) Visual acuity does NOT predict reading speed in patients with AMD

Clinical Predictors of Reading Speed in AMD ( Rubin & Feely, 2009) Visual acuity does NOT predict reading speed in patients with AMD Fixation stability and size of forward saccades account for 74% of variance. Reading Speed (words/min)

Scanning Laser Ophthalmoscope

Scotoma Map

Replacing the SLO? Nidek MP-1

Compensation for Fixation Instability Improves Reading Speed (Macedo, 2013)

RSVP Reading Once

RSVP Reading upon

a RSVP Reading

time RSVP Reading

there RSVP Reading

lived RSVP Reading

upon a time there lived a RSVP Reading

Once a time there a vain RSVP Reading

Emperor. RSVP Reading

RSVP Improves reading Speed

Training Possibilities Eccentric Viewing Eye Movement Training Perceptual Learning

Electronic Head-Mounted Devices Portable Cosmetically acceptable Lightweight Multipurpose Affordable (good value for money) Commercial support The ultimate HMD

Electronic Magnification Devices: 1990 Low Vision Enhancement System - LVES

Electronic Magnification Devices: 2001 Jordy®

Reading Performance with Devices

The Demise of Jordy and His Friends

Portable Electronic Low Vision Aids

PELVAs Pros –Less expensive (<£400) –Smartphone platform –Battery powered –Light and compact Cons –Limited field of view –Limited magnification Studies in progress

Implantable Miniature Telescope (IMT)

UK Clinical Trial of IMT (Dunbar, 2010) Prospective open label trial of 3x IMT at 4 UK centers IMT implanted in better eye of 17 patients Followed by 12-week rehab course Results –3 line improvement in VA –Contrast sensitivity reduced by 0.4 logCS –Maximum reading rate improved by 10 words/min –Self-reported visual disability (Massof AI) improved by 0.6 logit (equiv to 4 lines of VA)

Retinal Prostheses – ‘Bionic Eye’ About 10 projects worldwide Mostly epi-retinal; some sub- retinal Well tolerated and apparently safe Also optic nerve and cortical prostheses Initially, low resolution –20 electrodes max due to safety concerns Winter, et al (2007)

Argus II – Second Sight (California)

Epi-retinal 60 electrode array Implanted in about two dozen patients worldwide (12 in UK; 8 Moorfields) Retinitis pigmentosa with light perception or worse Outcome measures –Grating acuity –Phosphene projection –Letter recognition –Mobility Follow a white line on a black background Find a white door on a black wall

A Sampler of Clinical Trials Underway Impact of LV rehab in patients with diabetic eye disease (Dunbar, ) Eccentric Fixation From Enhanced Clinical Training, (EFFECT): A Randomised Controlled Trial for Patients with AMD (Rubin, ) Depression in Visual Impairment Trial (DEPVIT; Margrain, ) The impact of timely emotional support on the quality of life of blind and partially sighted people (Afsani, )

Summary and Conclusions Substantial growth in low vision research during the past 10 years Shifting emphasis from head-mounted low vision magnifier to portable hand-held electronic magnifier New initiatives in service delivery showing great promise Profusion of new outcome measures Building momentum in establishing a sound evidence base for the effectiveness of low vision rehabilitation Still plenty of additional work to be done!

Acknowledgements Collaborators –Louise Culham - Moorfields Eye Hospital –Alan Bird - Moorfields Eye Hospital –Liz Pearce – Moorfields Eye Hospital –Peter Bex –Fred Fitzke Postdocs and Students –Michael Crossland –Stamatina Kabanarou –Caren Bellmann –Angela Rees –Thomas Butt –Radhika Gulati –Hannah Dunbar –Anthony Chabra Research Assistants –Eugeniu Dinu –Mary Feely –Hannah Roche Funding –Wellcome Trust –National Institute of Health Research –Guide Dogs for the Blind Association –Macular Disease Society –European Commission –Fight for Sight –Special Trustees of Moorfields Eye Hospital –Garfield Weston Foundation –Friends of Moorfields Eye Hospital